Guardian Pharmacy Services (NYSE:GRDN) Director Sells $105,977,693.36 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director William Bindley sold 3,570,677 shares of Guardian Pharmacy Services stock in a transaction on Friday, March 20th. The shares were sold at an average price of $29.68, for a total value of $105,977,693.36. Following the transaction, the director owned 4,469,316 shares in the company, valued at approximately $132,649,298.88. This trade represents a 44.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Guardian Pharmacy Services Stock Performance

GRDN opened at $34.19 on Friday. The company has a market capitalization of $2.17 billion, a PE ratio of 44.41 and a beta of 0.86. The stock’s fifty day moving average is $32.88 and its 200-day moving average is $29.95. Guardian Pharmacy Services, Inc. has a one year low of $19.17 and a one year high of $38.12.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.10. The business had revenue of $397.62 million during the quarter, compared to analysts’ expectations of $390.04 million. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.The business’s quarterly revenue was up 17.4% compared to the same quarter last year. On average, equities research analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Hedge funds and other institutional investors have recently modified their holdings of the stock. Dynamic Technology Lab Private Ltd acquired a new stake in Guardian Pharmacy Services during the 1st quarter worth about $233,000. Envestnet Asset Management Inc. lifted its stake in Guardian Pharmacy Services by 7.1% during the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after buying an additional 805 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Guardian Pharmacy Services by 65.9% in the second quarter. Geode Capital Management LLC now owns 336,701 shares of the company’s stock worth $7,177,000 after buying an additional 133,715 shares during the period. Police & Firemen s Retirement System of New Jersey increased its position in shares of Guardian Pharmacy Services by 76.8% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after acquiring an additional 1,062 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Guardian Pharmacy Services in the second quarter worth approximately $346,000.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on GRDN. Truist Financial lifted their price objective on shares of Guardian Pharmacy Services from $34.00 to $38.00 and gave the stock a “buy” rating in a research note on Thursday, March 12th. Zacks Research raised shares of Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, March 18th. Stephens raised their target price on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, January 14th. Raymond James Financial restated an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $38.00.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.